Cargando…
MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
Autores principales: | Mata, Melinda, Gerken, Claudia, Spencer, David M, Gottschalk, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645182/ http://dx.doi.org/10.1186/2051-1426-3-S2-P118 |
Ejemplares similares
-
MyD88/CD40 signaling retains CAR T cells in a less differentiated state
por: Prinzing, Brooke, et al.
Publicado: (2020) -
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 co-stimulation
por: Vaidya, Abishek, et al.
Publicado: (2022) -
Synergy between CD40 and MyD88 Does Not Influence Host Survival to Salmonella Infection
por: Wenzel, Ulf Alexander, et al.
Publicado: (2015) -
P10-06. Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependence
por: Rhee, EG, et al.
Publicado: (2009) -
P15. A genetic mouse model to identify the role of the immune adapter protein MyD88 in colorectal cancer
por: Holtorf, A, et al.
Publicado: (2014)